Inflammation modulates RLIP76/RALBP1 electrophile-glutathione conjugate transporter and housekeeping genes in human blood-brain barrier endothelial cells

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Bennani Baiti, Barbara ^a,b   Toegel, Stefan ^b   Viernstein, Helmut ^a   Urban, Ernst ^a   Noe, Christian R ^a   Bennani Baiti, Idriss M ^c  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c B2 Scientific Group (B2SG)   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; BETA ACTIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MEMBRANE PROTEIN; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 1; RLIP76 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ABC TRANSPORTER; BIOLOGICAL MARKER; GLUTATHIONE; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; RALBP1 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR;

ACTB GENE; ALGORITHM; ARTICLE; B2M GENE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; ENDOTHELIUM CELL; GAPDH GENE; GENE EXPRESSION; HOUSEKEEPING GENE; HPRT1 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; PMM1 GENE; PSMB6 GENE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SDHA GENE; TRANSCRIPTION REGULATION; TUBA1B GENE; YWHAZ GENE; ANIMAL; BINDING SITE; DRUG EFFECTS; ESSENTIAL GENE; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION STUDY; GENETICS; METABOLISM; MOUSE; PATHOLOGY; PROMOTER REGION; RAT; SOFTWARE;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BINDING SITES; BIOMARKERS; BLOOD-BRAIN BARRIER; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; GENES, ESSENTIAL; GENETIC ASSOCIATION STUDIES; GLUTATHIONE; GTPASE-ACTIVATING PROTEINS; HUMANS; INFLAMMATION; MICE; NF-KAPPA B; PROMOTER REGIONS, GENETIC; RATS; SOFTWARE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84947235759     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0139101     Document Type: Article

References (107)

1. Golias C, Tsoutsi E, Matziridis A, Makridis P, Batistatou A, Charalabopoulos K. Review. Leukocyte and endothelial cell adhesion molecules in inflammation focusing on inflammatory heart disease. In Vivo. 2007; 21(5):757-69.
2. Schmid MC, Schulein R, Dehio M, Denecker G, Carena I, Dehio C. The VirB type IV secretion system of Bartonella henselae mediates invasion, proinflammatory activation and antiapoptotic protection of endothelial cells. Mol Microbiol. 2004; 52(1):81-92.
3. Vallance P, Collier J, Bhagat K. Infection, inflammation, and infarction: does acute endothelial dysfunction provide a link? Lancet. 1997; 349(9062):1391-2.
4. Silva Y, Leira R, Tejada J, Lainez JM, Castillo J, Davalos A. Molecular signatures of vascular injury are associated with early growth of intracerebral hemorrhage. Stroke. 2005; 36(1):86-91.
5. Marboeuf P, Corseaux D, Mouquet F, Van Belle E, Jude B, Susen S. Inflammation triggers colony forming endothelial cell mobilization after angioplasty in chronic lower limb ischemia. J Thromb Haemost. 2008; 6(1):195-7.
6. Beekhuizen H, van de Gevel JS. Endothelial cell adhesion molecules in inflammation and postischemic reperfusion injury. Transplant Proc. 1998; 30(8):4251-6.
7. Kupatt C, Habazettl H, Becker BF, Boekstegers P. Endothelial activation-A strategic event during postischemic myocardial inflammation. Z Kardiol. 2000; 89 Suppl 9:IX/96-100.
8. Arnaud C, Mach F. Pleiotropic effects of statins in atherosclerosis: role on endothelial function, inflammation and immunomodulation. Arch Mal Coeur Vaiss. 2005; 98(6):661-6.
9. Gimbrone MA Jr., Bevilacqua MP, Cybulsky MI. Endothelial-dependent mechanisms of leukocyte adhesion in inflammation and atherosclerosis. Ann N Y Acad Sci. 1990; 598:77-85.
10. Lahera V, Goicoechea M, de Vinuesa SG, Miana M, de las Heras N, Cachofeiro V, et al. Endothelial dysfunction, oxidative stress and inflammation in atherosclerosis: beneficial effects of statins. Curr Med Chem. 2007; 14(2):243-8.
11. Deban L, Correale C, Vetrano S, Malesci A, Danese S. Multiple pathogenic roles of microvasculature in inflammatory bowel disease: A Jack of all trades. Am J Pathol. 2008; 172(6):1457-66. doi: 10.2353/ajpath.2008.070593
12. Horowitz S, Binion DG, Nelson VM, Kanaa Y, Javadi P, Lazarova Z, et al. Increased arginase activity and endothelial dysfunction in human inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol. 2007; 292(5):G1323-36.
13. Schinzari F, Armuzzi A, De Pascalis B, Mores N, Tesauro M, Melina D, et al. Tumor necrosis factoralpha antagonism improves endothelial dysfunction in patients with Crohn's disease. Clin Pharmacol Ther. 2008; 83(1):70-6.
14. Minagar A, Jy W, Jimenez JJ, Alexander JS. Multiple sclerosis as a vascular disease. Neurol Res. 2006; 28(3):230-5.
15. Higashi Y, Goto C, Jitsuiki D, Umemura T, Nishioka K, Hidaka T, et al. Periodontal infection is associated with endothelial dysfunction in healthy subjects and hypertensive patients. Hypertension. 2008; 51(2):446-53.
16. Moutsopoulos NM, Madianos PN. Low-grade inflammation in chronic infectious diseases: paradigm of periodontal infections. Ann N Y Acad Sci. 2006; 1088:251-64.
17. Seinost G, Wimmer G, Skerget M, Thaller E, Brodmann M, Gasser R, et al. Periodontal treatment improves endothelial dysfunction in patients with severe periodontitis. Am Heart J. 2005; 149 (6):1050-4.
18. Tonetti MS, D'Aiuto F, Nibali L, Donald A, Storry C, Parkar M, et al. Treatment of periodontitis and endothelial function. N Engl J Med. 2007; 356(9):911-20.
19. Gonzalez-Gay MA, Gonzalez-Juanatey C, Martin J. Inflammation and endothelial dysfunction in rheumatoid arthritis. Clin Exp Rheumatol. 2006; 24(2):115-7.
20. Kerekes G, Szekanecz Z, Der H, Sandor Z, Lakos G, Muszbek L, et al. Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: A multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity. J Rheumatol. 2008; 35(3):398-406.
21. Antoniades C, Tousoulis D, Marinou K, Papageorgiou N, Bosinakou E, Tsioufis C, et al. Effects of insulin dependence on inflammatory process, thrombotic mechanisms and endothelial function, in patients with type 2 diabetes mellitus and coronary atherosclerosis. Clin Cardiol. 2007; 30(6):295-300.
22. Leinonen ES, Hiukka A, Hurt-Camejo E, Wiklund O, Sarna SS, Mattson Hulten L, et al. Low-grade inflammation, endothelial activation and carotid intima-media thickness in type 2 diabetes. J Intern Med. 2004; 256(2):119-27.
23. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008; 454 (7203):436-44. Epub 2008/07/25. nature07205 [pii] doi: 10.1038/nature07205.
24. Pitroda SP, Zhou T, Sweis RF, Filippo M, Labay E, Beckett MA, et al. Tumor endothelial inflammation predicts clinical outcome in diverse human cancers. PLoS One. 2012; 7(10):e46104. Epub 2012/10/12. doi: 10.1371/journal.pone.0046104 PONE-D-12-07623 [pii].
25. Kalinowska A, Losy J. PECAM-1, a key player in neuroinflammation. Eur J Neurol. 2006; 13 (12):1284-90.
26. Sharief MK, Ciardi M, Thompson EJ. Blood-brain barrier damage in patients with bacterial meningitis: Association with tumor necrosis factor-Alpha but not interleukin-1 beta. J Infect Dis. 1992; 166(2):350-8.
27. Beck KD, Nguyen HX, Galvan MD, Salazar DL, Woodruff TM, Anderson AJ. Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment. Brain. 2010; 133(Pt 2):433-47. Epub 2010/01/21. doi: 10.1093/brain/awp322 awp322 [pii].
28. Chapouly C, Tadesse Argaw A, Horng S, Castro K, Zhang J, Asp L, et al. Astrocytic TYMP and VEGFA drive blood-brain barrier opening in inflammatory central nervous system lesions. Brain. 2015; 138(Pt 6):1548-67. Epub 2015/03/26. doi: 10.1093/brain/awv077 awv077 [pii].
29. Minten C, Alt C, Gentner M, Frei E, Deutsch U, Lyck R, et al. DARC shuttles inflammatory chemokines across the blood-brain barrier during autoimmune central nervous system inflammation. Brain. 2014; 137(Pt 5):1454-69. Epub 2014/03/15. doi: 10.1093/brain/awu045 awu045 [pii].
30. Stamatovic SM, Dimitrijevic OB, Keep RF, Andjelkovic AV. Inflammation and brain edema: new insights into the role of chemokines and their receptors. Acta Neurochir Suppl. 2006; 96:444-50.
31. Liu JY, Thom M, Catarino CB, Martinian L, Figarella-Branger D, Bartolomei F, et al. Neuropathology of the blood-brain barrier and pharmaco-resistance in human epilepsy. Brain. 2012; 135(Pt 10):3115-33. Epub 2012/07/04. doi: 10.1093/brain/aws147 aws147 [pii].
32. Vezzani A, Granata T. Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia. 2005; 46(11):1724-43.
33. Carvey PM, Zhao CH, Hendey B, Lum H, Trachtenberg J, Desai BS, et al. 6-Hydroxydopamineinduced alterations in blood-brain barrier permeability. Eur J Neurosci. 2005; 22(5):1158-68.
34. Wilms H, Zecca L, Rosenstiel P, Sievers J, Deuschl G, Lucius R. Inflammation in Parkinson's diseases and other neurodegenerative diseases: cause and therapeutic implications. Curr Pharm Des. 2007; 13(18):1925-8.
35. Franscini N, Bachli EB, Blau N, Leikauf MS, Schaffner A, Schoedon G. Gene expression profiling of inflamed human endothelial cells and influence of activated protein C. Circulation. 2004; 110 (18):2903-9.
36. Gu J, Chen Y, Li S, Li Y. Identification of responsive gene modules by network-based gene clustering and extending: Application to inflammation and angiogenesis. BMC Syst Biol. 2010; 4:47. Epub 2010/04/22. doi: 10.1186/1752-0509-4-47 1752-0509-4-47 [pii].
37. Lok CA, Boing AN, Reitsma PH, van der Post JA, van Bavel E, Boer K, et al. Expression of inflammation-related genes in endothelial cells is not directly affected by microparticles from preeclamptic patients. J Lab Clin Med. 2006; 147(6):310-20.
38. Zhou J, Jin Y, Gao Y, Wang H, Hu G, Huang Y, et al. Genomic-scale analysis of gene expression profiles in TNF-Alpha treated human umbilical vein endothelial cells. Inflamm Res. 2002; 51(7):332-41.
39. De Martin R, Hoeth M, Hofer-Warbinek R, Schmid JA. The transcription factor NF-kappa B and the regulation of vascular cell function. Arterioscler Thromb Vasc Biol. 2000; 20(11):E83-8.
40. Kracht M, Saklatvala J. Transcriptional and post-Transcriptional control of gene expression in inflammation. Cytokine. 2002; 20(3):91-106.
41. Lee YW, Eum SY, Chen KC, Hennig B, Toborek M. Gene expression profile in interleukin-4-stimulated human vascular endothelial cells. Mol Med. 2004; 10(1-6):19-27.
42. Rahman I. Oxidative stress, chromatin remodeling and gene transcription in inflammation and chronic lung diseases. J Biochem Mol Biol. 2003; 36(1):95-109.
43. Ruminy P, Gangneux C, Claeyssens S, Scotte M, Daveau M, Salier JP. Gene transcription in hepatocytes during the acute phase of a systemic inflammation: from transcription factors to target genes. Inflamm Res. 2001; 50(8):383-90.
44. Mori R, Wang Q, Danenberg KD, Pinski JK, Danenberg PV. Both beta-Actin and GAPDH are useful reference genes for normalization of quantitative RT-PCR in human FFPE tissue samples of prostate cancer. Prostate. 2008; 68(14):1555-60. doi: 10.1002/pros.20815
45. Murthi P, Fitzpatrick E, Borg AJ, Donath S, Brennecke SP, Kalionis B. GAPDH, 18S rRNA and YWHAZ are suitable endogenous reference genes for relative gene expression studies in placental tissues from human idiopathic fetal growth restriction. Placenta. 2008; 29(9):798-801. doi: 10.1016/j.placenta.2008.06.007
46. Cummings M, Sarveswaran J, Homer-Vanniasinkam S, Burke D, Orsi NM. Glyceraldehyde-3-phosphate Dehydrogenase is an Inappropriate Housekeeping Gene for Normalising Gene Expression in Sepsis. Inflammation. 2014; 37(5):1889-94. Epub 2014/05/27. doi: 10.1007/s10753-014-9920-3.
47. Thorrez L, Van Deun K, Tranchevent LC, Van Lommel L, Engelen K, Marchal K, et al. Using ribosomal protein genes as reference: A tale of caution. PLoS ONE. 2008; 3(3):e1854. doi: 10.1371/journal.pone.0001854
48. Bamias G, Goukos D, Laoudi E, Balla IG, Siakavellas SI, Daikos GL, et al. Comparative study of candidate housekeeping genes for quantification of target gene messenger RNA expression by real-Time PCR in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2013; 19(13):2840-7. Epub 2013/10/22. doi: 10.1097/01.MIB.0000435440.22484.e8.
49. Montero-Melendez T, Perretti M. Gapdh gene expression is modulated by inflammatory arthritis and is not suitable for qPCR normalization. Inflammation. 2014; 37(4):1059-69. Epub 2014/02/05. doi: 10. 1007/s10753-014-9829-x.
50. Barar J, Gumbleton M, Asadi M, Omidi Y. Barrier functionality and transport machineries of human ECV304 cells. Med Sci Monit. 2010; 16(1):BR52-60. Epub 2009/12/29. 878321 [pii].
51. Gonzalez-Burgos E, Carretero ME, Gomez-Serranillos MP. In vitro permeability study of CNS-Active diterpenes from Sideritis spp. using cellular models of blood-brain barrier. Planta Med. 2013; 79 (16):1545-51. Epub 2013/09/14. doi: 10.1055/s-0033-1350797.
52. Liverani E, Paul C. Glucocorticoids alter adrenomedullin receptor expression and secretion in endothelial-like cells and astrocytes. Int J Biochem Cell Biol. 2013; 45(12):2715-23. Epub 2013/10/08. doi: 10.1016/j.biocel.2013.09.009 S1357-2725(13)00298-7 [pii].
53. Neuhaus W, Freidl M, Szkokan P, Berger M, Wirth M, Winkler J, et al. Effects of NMDA receptor modulators on a blood-brain barrier in vitro model. Brain Res. 2011; 1394:49-61. Epub 2011/05/10. doi: 10.1016/j.brainres.2011.04.003 S0006-8993(11)00670-6 [pii].
54. Neuhaus W, Mandikova J, Pawlowitsch R, Linz B, Bennani-Baiti B, Lauer R, et al. Blood-brain barrier in vitro models as tools in drug discovery: Assessment of the transport ranking of antihistaminic drugs. Pharmazie. 2012; 67(5):432-9. Epub 2012/07/07.
55. Novakova I, Subileau EA, Toegel S, Gruber D, Lachmann B, Urban E, et al. Transport rankings of non-steroidal antiinflammatory drugs across blood-brain barrier in vitro models. PLoS One. 2014; 9 (1):e86806. Epub 2014/01/28. doi: 10.1371/journal.pone.0086806 PONE-D-13-36709 [pii].
56. Poetsch V, Bennani-Baiti B, Neuhaus W, Muchitsch EM, Noe CR. Serum-derived immunoglobulins alter amyloid beta transport across a blood-brain barrier in vitro model. Pharmazie. 2010; 65(4):267-73. Epub 2010/05/04.
57. Rodriguez-Gaztelumendi A, Alvehus M, Andersson T, Jacobsson SO. Comparison of the effects of nicotine upon the transcellular electrical resistance and sucrose permeability of human ECV304/rat C6 co-cultures and human CaCo(2) cells. Toxicol Lett. 2011; 207(1):1-6. Epub 2011/09/06. doi: 10. 1016/j.toxlet.2011.08.014 S0378-4274(11)01500-1 [pii].
58. Untucht C, Rasch J, Fuchs E, Rohde M, Bergmann S, Steinert M. An optimized in vitro blood-brain barrier model reveals bidirectional transmigration of African trypanosome strains. Microbiology. 2011; 157(Pt 10):2933-41. Epub 2011/07/09. doi: 10.1099/mic.0.049106-0 mic.0.049106-0 [pii].
59. Wang GY, Wang N, Liao HN. Effects of Muscone on the Expression of P-gp, MMP-9 on Blood-Brain Barrier Model In Vitro. Cell Mol Neurobiol. in press. Epub 2015/05/16. doi: 10.1007/s10571-015-0204-8.
60. Wang LF, Li X, Gao YB, Wang SM, Zhao L, Dong J, et al. Activation of VEGF/Flk-1-ERK Pathway Induced Blood-Brain Barrier Injury After Microwave Exposure. Mol Neurobiol. 2014. Epub 2014/09/10. doi: 10.1007/s12035-014-8848-9.
61. Wang Q, Luo W, Zhang W, Liu M, Song H, Chen J. Involvement of DMT1 +IRE in the transport of lead in an in vitro BBB model. Toxicol In Vitro. 2011; 25(4):991-8. Epub 2009/11/17. doi: 10.1016/j.tiv. 2009.11.006 S0887-2333(09)00335-X [pii].
62. Plattner VE, Germann B, Neuhaus W, Noe CR, Gabor F, Wirth M. Characterization of two blood-brain barrier mimicking cell lines: distribution of lectin-binding sites and perspectives for drug delivery. Int J Pharm. 2010; 387(1-2):34-41. Epub 2009/12/08. doi: 10.1016/j.ijpharm.2009.11.030 S0378-5173 (09)00851-5 [pii].
63. Bennani-Baiti B, Bennani-Baiti IM. Gene symbol precision. Gene. 2012; 491(2):103-9. Epub 2011/10/25. S0378-1119(11)00562-2 [pii] doi: 10.1016/j.gene.2011.09.035.
64. Bustin SA, Benes V, Garson J, Hellemans J, Huggett J, Kubista M, et al. The need for transparency and good practices in the qPCR literature. Nat Methods. 2013; 10(11):1063-7. Epub 2013/11/01. doi: 10.1038/nmeth.2697 nmeth.2697 [pii].
65. Bustin SA, Beaulieu JF, Huggett J, Jaggi R, Kibenge FS, Olsvik PA, et al. MIQE precis: Practical implementation of minimum standard guidelines for fluorescence-based quantitative real-Time PCR experiments. BMC Mol Biol. 2010; 11:74. Epub 2010/09/23. doi: 10.1186/1471-2199-11-74 1471-2199-11-74 [pii].
66. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, et al. Accurate normalization of real-Time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002; 3(7):RESEARCH0034. Epub 2002/08/20.
67. Andersen CL, Jensen JL, Orntoft TF. Normalization of real-Time quantitative reverse transcription-PCR data: A model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res. 2004; 64(15):5245-50.
68. Pfaffl MW, Tichopad A, Prgomet C, Neuvians TP. Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper-Excel-based tool using pair-wise correlations. Biotechnol Lett. 2004; 26(6):509-15.
69. Bennani-Baiti IM, Cooper A, Lawlor ER, Kauer M, Ban J, Aryee DN, et al. Intercohort gene expression co-Analysis reveals chemokine receptors as prognostic indicators in Ewing's sarcoma. Clin Cancer Res. 2010; 16(14):3769-78. Epub 2010/06/08. doi: 10.1158/1078-0432.CCR-10-0558 1078-0432. CCR-10-0558 [pii].
70. Bennani-Baiti IM, Aryee DN, Ban J, Machado I, Kauer M, Muhlbacher K, et al. Notch signalling is off and is uncoupled from HES1 expression in Ewing's sarcoma. J Pathol. 2011; 225(3):353-63. Epub 2011/10/11. doi: 10.1002/path.2966.
71. Lukk M, Kapushesky M, Nikkila J, Parkinson H, Goncalves A, Huber W, et al. A global map of human gene expression. Nat Biotechnol. 2010; 28(4):322-4. Epub 2010/04/10. doi: 10.1038/nbt0410-322 nbt0410-322 [pii].
72. Chen G, Zhao L, Feng J, You G, Sun Q, Li P, et al. Validation of reliable reference genes for real-Time PCR in human umbilical vein endothelial cells on substrates with different stiffness. PLoS One. 2013; 8(6):e67360. Epub 2013/07/11. doi: 10.1371/journal.pone.0067360 PONE-D-13-02338 [pii].
73. Wei R, Stewart EA, Amoaku WM. Suitability of endogenous reference genes for gene expression studies with human intraocular endothelial cells. BMC Res Notes. 2013; 6:46. Epub 2013/02/06. doi: 10.1186/1756-0500-6-46 1756-0500-6-46 [pii].
74. Zyzynska-Granica B, Koziak K. Identification of suitable reference genes for real-Time PCR analysis of statin-Treated human umbilical vein endothelial cells. PLoS One. 2012; 7(12):e51547. Epub 2012/12/20. doi: 10.1371/journal.pone.0051547 PONE-D-12-17286 [pii].
75. Garcia-Vallejo JJ, Van Het Hof B, Robben J, Van Wijk JA, Van Die I, Joziasse DH, et al. Approach for defining endogenous reference genes in gene expression experiments. Anal Biochem. 2004; 329 (2):293-9.
76. Pinhu L, Park JE, Yao W, Griffiths MJ. Reference gene selection for real-Time polymerase chain reaction in human lung cells subjected to cyclic mechanical strain. Respirology. 2008; 13(7):990-9. doi: 10.1111/j.1440-1843.2008.01396.x
77. Liu PQ, Rebar EJ, Zhang L, Liu Q, Jamieson AC, Liang Y, et al. Regulation of an endogenous locus using a panel of designed zinc finger proteins targeted to accessible chromatin regions. Activation of vascular endothelial growth factor A. J Biol Chem. 2001; 276(14):11323-34. Epub 2001/01/19. doi: 10.1074/jbc.M011172200 M011172200 [pii].
78. Bennani-Baiti IM, Asa SL, Song D, Iratni R, Liebhaber SA, Cooke NE. DNase I-hypersensitive sites I and II of the human growth hormone locus control region are a major developmental activator of somatotrope gene expression. Proc Natl Acad Sci U S A. 1998; 95(18):10655-60. Epub 1998/09/02.
79. Kwon MJ, Oh E, Lee S, Roh MR, Kim SE, Lee Y, et al. Identification of novel reference genes using multiplatform expression data and their validation for quantitative gene expression analysis. PLoS One. 2009; 4(7):e6162. Epub 2009/07/09. doi: 10.1371/journal.pone.0006162
80. Moskalenko S, Henry DO, Rosse C, Mirey G, Camonis JH, White MA. The exocyst is a Ral effector complex. Nat Cell Biol. 2002; 4(1):66-72. Epub 2001/12/12. doi: 10.1038/ncb728 ncb728 [pii].
81. Sugihara K, Asano S, Tanaka K, Iwamatsu A, Okawa K, Ohta Y. The exocyst complex binds the small GTPase RalA to mediate filopodia formation. Nat Cell Biol. 2002; 4(1):73-8. Epub 2001/12/18. doi: 10.1038/ncb720 ncb720 [pii].
82. Vandenbroucke E, Mehta D, Minshall R, Malik AB. Regulation of endothelial junctional permeability. Ann N Y Acad Sci. 2008; 1123:134-45. Epub 2008/04/01. 1123/1/134 [pii] doi: 10.1196/annals.1420.016.
83. Lee S, Wurtzel JG, Goldfinger LE. The RLIP76 N-Terminus binds ARNO to regulate PI 3-kinase, Arf6 and Rac signaling, cell spreading and migration. Biochem Biophys Res Commun. 2014; 454(4):560-5. Epub 2014/12/03. S0006-291X(14)01934-2 [pii] doi: 10.1016/j.bbrc.2014.10.114
84. Lee S, Goldfinger LE. RLIP76 regulates HIF-1 activity, VEGF expression and secretion in tumor cells, and secretome transactivation of endothelial cells. FASEB J. 2014; 28(9):4158-68. Epub 2014/06/15. doi: 10.1096/fj.14-255711 fj.14-255711 [pii].
85. Lee S, Wurtzel JG, Singhal SS, Awasthi S, Goldfinger LE. RALBP1/RLIP76 depletion in mice suppresses tumor growth by inhibiting tumor neovascularization. Cancer Res. 2012; 72(20):5165-73. Epub 2012/08/21. doi: 10.1158/0008-5472.CAN-12-0468 0008-5472.CAN-12-0468 [pii].
86. Awasthi S, Hallene KL, Fazio V, Singhal SS, Cucullo L, Awasthi YC, et al. RLIP76, a non-ABC transporter, and drug resistance in epilepsy. BMC Neurosci. 2005; 6:61. Epub 2005/09/29.1471-2202-6-61 [pii] doi: 10.1186/1471-2202-6-61
87. Awasthi S, Singhal SS, Awasthi YC, Martin B, Woo JH, Cunningham CC, et al. RLIP76 and Cancer. Clin Cancer Res. 2008; 14(14):4372-7. Epub 2008/07/17. 14/14/4372 [pii] doi: 10.1158/1078-0432. CCR-08-0145
88. Lim KH, Baines AT, Fiordalisi JJ, Shipitsin M, Feig LA, Cox AD, et al. Activation of RalA is critical for Ras-induced tumorigenesis of human cells. Cancer Cell. 2005; 7(6):533-45. Epub 2005/06/14. S1535-6108(05)00157-1 [pii] doi: 10.1016/j.ccr.2005.04.030.
89. Singhal SS, Sehrawat A, Sahu M, Singhal P, Vatsyayan R, Rao Lelsani PC, et al. Rlip76 transports sunitinib and sorafenib and mediates drug resistance in kidney cancer. Int J Cancer. 2010; 126 (6):1327-38. Epub 2009/07/25. doi: 10.1002/ijc.24767
90. Singhal SS, Yadav S, Roth C, Singhal J. RLIP76: A novel glutathione-conjugate and multi-drug transporter. Biochem Pharmacol. 2009; 77(5):761-9. Epub 2008/11/06. S0006-2952(08)00715-6 [pii] doi: 10.1016/j.bcp.2008.10.006
91. Singhal SS, Yadav S, Singhal J, Zajac E, Awasthi YC, Awasthi S. Depletion of RLIP76 sensitizes lung cancer cells to doxorubicin. Biochem Pharmacol. 2005; 70(3):481-8. Epub 2005/06/14. S0006-2952 (05)00312-6 [pii] doi: 10.1016/j.bcp.2005.05.005.
92. Vatsyayan R, Chaudhary P, Lelsani PC, Singhal P, Awasthi YC, Awasthi S, et al. Role of RLIP76 in doxorubicin resistance in lung cancer. Int J Oncol. 2009; 34(6):1505-11. Epub 2009/05/09.
93. Vatsyayan R, Lelsani PC, Awasthi S, Singhal SS. RLIP76: A versatile transporter and an emerging target for cancer therapy. Biochem Pharmacol. 2010; 79(12):1699-705. Epub 2010/01/26. doi: 10.1016/j.bcp.2010.01.016 S0006-2952(10)00027-4 [pii].
94. Bae YS, Chung W, Han K, Park KY, Kim H, Kim E, et al. Down-regulation of RalBP1 expression reduces seizure threshold and synaptic inhibition in mice. Biochem Biophys Res Commun. 2013; 433 (2):175-80. Epub 2013/03/15. doi: 10.1016/j.bbrc.2013.02.056 S0006-291X(13)00316-1 [pii].
95. Birukov KG, Bochkov VN, Birukova AA, Kawkitinarong K, Rios A, Leitner A, et al. Epoxycyclopentenone-containing oxidized phospholipids restore endothelial barrier function via Cdc42 and Rac. Circ Res. 2004; 95(9):892-901. Epub 2004/10/09. 01.RES.0000147310.18962.06 [pii] doi: 10.1161/01. RES.0000147310.18962.06.
96. Zhao D, Kuhnt-Moore S, Zeng H, Pan A, Wu JS, Simeonidis S, et al. Substance P-stimulated interleukin-8 expression in human colonic epithelial cells involves Rho family small GTPases. Biochem J. 2002; 368(Pt 2):665-72. Epub 2002/08/10. doi: 10.1042/BJ20020950 BJ20020950 [pii].
97. Zhao D, Kuhnt-Moore S, Zeng H, Wu JS, Moyer MP, Pothoulakis C. Neurotensin stimulates IL-8 expression in human colonic epithelial cells through Rho GTPase-mediated NF-kappa B pathways. Am J Physiol Cell Physiol. 2003; 284(6):C1397-404. Epub 2003/02/14. doi: 10.1152/ajpcell.00328.2002 00328.2002 [pii].
98. Hunt C, Morimoto RI. Conserved features of eukaryotic hsp70 genes revealed by comparison with the nucleotide sequence of human hsp70. Proc Natl Acad Sci U S A. 1985; 82(19):6455-9. Epub 1985/10/01.
99. Duret L, Bucher P. Searching for regulatory elements in human noncoding sequences. Curr Opin Struct Biol. 1997; 7(3):399-406. Epub 1997/06/01. S0959-440X(97)80058-9 [pii].
100. Tian H, Cao L, Tan Y, Williams S, Chen L, Matray T, et al. Multiplex mRNA assay using electrophoretic tags for high-Throughput gene expression analysis. Nucleic Acids Res. 2004; 32(16):e126. Epub 2004/09/10. doi: 10.1093/nar/gnh119 32/16/e126 [pii].
101. Ammar Z, Plazolles N, Baltz T, Coustou V. Identification of trans-sialidases as a common mediator of endothelial cell activation by African trypanosomes. PLoS Pathog. 2013; 9(10):e1003710. Epub 2013/10/17. doi: 10.1371/journal.ppat.1003710 PPATHOGENS-D-13-01000 [pii].
102. Walker L, Sills GJ. Inflammation and epilepsy: The foundations for a new therapeutic approach in epilepsy? Epilepsy Curr. 2012; 12(1):8-12. Epub 2012/03/01. doi: 10.5698/1535-7511-12.1.8
103. Gorter JA, van Vliet EA, Aronica E. Status epilepticus, blood-brain barrier disruption, inflammation, and epileptogenesis. Epilepsy Behav. 2015. Epub 2015/05/11. S1525-5050(15)00216-4 [pii] doi: 10.1016/j.yebeh.2015.04.047.
104. de Souza Bernardino TC, Teixeira AL, Miranda AS, Guidine PM, Rezende G, Doretto MC, et al. Wistar Audiogenic Rats (WAR) exhibit altered levels of cytokines and brain-derived neurotrophic factor following audiogenic seizures. Neurosci Lett. 2015; 597:154-8. Epub 2015/05/06. doi: 10.1016/j.neulet. 2015.04.046 S0304-3940(15)00345-6 [pii].
105. Dupuis N, Auvin S. Inflammation and epilepsy in the developing brain: clinical and experimental evidence. CNS Neurosci Ther. 2015; 21(2):141-51. Epub 2015/01/22. doi: 10.1111/cns.12371.
106. Tudur Smith C, Marson AG, Clough HE, Williamson PR. Carbamazepine versus phenytoin monotherapy for epilepsy. Cochrane Database Syst Rev. 2002;(2: ):CD001911. Epub 2002/06/22. CD001911 [pii] doi: 10.1002/14651858.CD001911.
107. Kaminski R, Kozicka M, Parada-Turska J, Dziki M, Kleinrok Z, Turski WA, et al. Effect of non-steroidal anti-inflammatory drugs on the anticonvulsive activity of valproate and diphenylhydantoin against maximal electroshock-induced seizures in mice. Pharmacol Res. 1998; 37(5):375-81. Epub 1998/06/27. S1043-6618(98)90309-7 [pii] doi: 10.1006/phrs.1998.0309.